A, V., Ó, B., J, B., J, G., L, P., C, B., . . . S, R. (2025). PBMCs gene expression predicts liver fibrosis regression after successful HCV therapy in HIV/HCV-coinfected patients. Frontiers in pharmacology, 15, 1436198. https://doi.org/10.3389/fphar.2024.1436198
Chicago Style (17th ed.) CitationA, Virseda-Berdices, et al. "PBMCs Gene Expression Predicts Liver Fibrosis Regression After Successful HCV Therapy in HIV/HCV-coinfected Patients." Frontiers in Pharmacology 15 (2025): 1436198. https://doi.org/10.3389/fphar.2024.1436198.
MLA (9th ed.) CitationA, Virseda-Berdices, et al. "PBMCs Gene Expression Predicts Liver Fibrosis Regression After Successful HCV Therapy in HIV/HCV-coinfected Patients." Frontiers in Pharmacology, vol. 15, 2025, p. 1436198, https://doi.org/10.3389/fphar.2024.1436198.